Jim Simons's position in Vaxcyte is currently worth $1.29M. That's 0.00% of their equity portfolio (2047th largest holding). The first Vaxcyte trade was made in Q4 2021. Since then Jim Simons bought shares seven more times and sold shares on seven occasions. The investor's estimated purchase price is $1.4M, resulting in a loss of 7.6%.